Lux Ventures Iv, L.P. Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Lux Ventures Iv, L.P. is of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 13 Million shares of RXRX, which is worth approximately $96.2 Million. The most recent transaction as insider was on Dec 07, 2021, when has been sold 4,265,576 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13M
0% 3M change
0% 12M change
Total Value Held $96.2 Million

Lux Ventures IV, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2021
SELL
Other acquisition or disposition
-
4,265,576 Reduced 24.67%
13,021,519 Class A Common Stock

Also insider at

LTCH
Latch, Inc. Technology
> 10% Shareholder
LVI

Lux Ventures Iv, L.P.

New York, NY

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX